Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126263181 | 12626318 | 1 | I | 20081201 | 20090407 | 20160805 | 20160805 | EXP | GB-ASTELLAS-2009001064 | ASTELLAS | 58.91 | YR | F | Y | 0.00000 | 20160805 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126263181 | 12626318 | 1 | PS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | 4350 | MG | N | 0 | 150 | MG | FORMULATION UNKNOWN | QD | ||||
| 126263181 | 12626318 | 2 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | 4350 | MG | 0 | FORMULATION UNKNOWN | |||||||||
| 126263181 | 12626318 | 3 | C | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | U | 0 | 2.5 | MG | FORMULATION UNKNOWN | QD | ||||||
| 126263181 | 12626318 | 4 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | U | 0 | 150 | MG | FORMULATION UNKNOWN | QD | ||||||
| 126263181 | 12626318 | 5 | C | CO CODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | 30/500 MG, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 126263181 | 12626318 | 6 | C | DIAZEPAM. | DIAZEPAM | 1 | Oral | UNK, AS NEEDED | U | 0 | CAPSULE | ||||||||
| 126263181 | 12626318 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 0 | 20 | MG | FORMULATION UNKNOWN | |||||||
| 126263181 | 12626318 | 8 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 6 | MG | FORMULATION UNKNOWN | |||||||
| 126263181 | 12626318 | 9 | C | ZOPICLONE | ZOPICLONE | 1 | Oral | U | 0 | 7.5 | MG | FORMULATION UNKNOWN | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126263181 | 12626318 | 1 | Non-small cell lung cancer |
| 126263181 | 12626318 | 2 | Metastases to central nervous system |
| 126263181 | 12626318 | 3 | Hypertension |
| 126263181 | 12626318 | 4 | Depression |
| 126263181 | 12626318 | 5 | Product used for unknown indication |
| 126263181 | 12626318 | 6 | Product used for unknown indication |
| 126263181 | 12626318 | 7 | Product used for unknown indication |
| 126263181 | 12626318 | 8 | Product used for unknown indication |
| 126263181 | 12626318 | 9 | Sedation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126263181 | 12626318 | DE |
| 126263181 | 12626318 | OT |
| 126263181 | 12626318 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126263181 | 12626318 | Dyspnoea | |
| 126263181 | 12626318 | Malignant neoplasm progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126263181 | 12626318 | 1 | 20081103 | 20081202 | 0 | |
| 126263181 | 12626318 | 3 | 200809 | 0 | ||
| 126263181 | 12626318 | 4 | 200711 | 0 | ||
| 126263181 | 12626318 | 5 | 200801 | 0 | ||
| 126263181 | 12626318 | 6 | 200811 | 0 | ||
| 126263181 | 12626318 | 7 | 200809 | 0 | ||
| 126263181 | 12626318 | 8 | 200809 | 0 | ||
| 126263181 | 12626318 | 9 | 20081201 | 20081204 | 0 |